Abstract
We have compared the membrane transport and antitumor activity of pirarubicin with those of doxorubicin in M5076 ovarian sarcoma, which exhibits low sensitivity to doxorubicin. Pirarubicin was rapidly taken up by M5076 cells and the intracellular concentration of pirarubicin reached more than 2.5‐fold that of doxorubicin. In terms of the 50% cell growth‐inhibitory concentration in vitro, pirarubicin was more effective than doxorubicin. Thus, the intracellular concentration influenced the cytotoxicity of these anthracycline agents. On comparison of the nuclear uptake of pirarubicin and doxorubicin, the nucleus/cell ratio of pirarubicin was found to be about 40%, whereas that of doxorubicin reached more than 80%. As the intranuclear concentration of pirarubicin is dependent on nuclear transport, the increases in not only cell membrane transport, but also nuclear membrane transport contributed to the enhancement of the efficacy of pirarubicin. In M5076 solid tumor‐bearing mice, pirarubicin reduced the tumor weight to 60% of the control level, although doxorubicin had no effect. These results were supported by the intracellular uptake of pirarubicin. Moreover, theanine, which inhibited the pirarubicin efflux from M5076 cells, increased by 1.3‐fold the pirarubicin concentration in the tumor and enhanced the therapeutic efficacy of pirarubicin 1.7‐fold. In conclusion, our results suggest that an increase in the concentration of an anthracycline derivative in tumor cells due to alteration of cell membrane transport results in enhancement of the antitumor activity.
Keywords: Pirarubicin, Doxorubicin, Theanine, Cancer chemotherapy, Nuclear uptake
Full Text
The Full Text of this article is available as a PDF (95.3 KB).
REFERENCES
- 1).Goren , D. , Gabizon , A. and Barenholz , Y.The influence of physical characteristics of liposomes containing doxorubicin on their pharmacological behavior . Biochim. Biophys. Acta , 1029 , 285 – 294 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 2).Sadzuka , Y. , Nakai , S. , Miyagishima , A. , Nozawa , Y. and Hirota , S.The effect of dose on the distribution of adriamycin encapsulated in polyethyleneglycol‐coated liposomes . J. Drug Target. , 3 , 31 – 37 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 3).Sadzuka , Y. , Hirotsu , S. , Miyagishima , A. , Nozawa , Y. and Hirota , S.The study of polyethyleneglycol‐coated liposomes containing CPT‐11 . J. Liposome Res. , 7 , 241 – 260 ( 1997. ). [Google Scholar]
- 4).Hamada , H. and Tsuruo , T.Functional role for 170‐ to 180‐kDa glycoprotein specific to drug‐resistant tumor cells as revealed by monoclonal antibodies . Proc. Natl. Acad. Sci. USA , 83 , 7785 – 7789 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5).Simon , S. M. and Schindlert , M.Cell biological mechanisms of multidrug resistance in tumors . Proc. Natl. Acad. Sci. USA , 91 , 3497 – 3504 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6).Nagasawa , K. , Natazuka , T. , Nomiyama , M. , Ohnishi , N. and Yokoyama , T.Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of daunorubicin and doxorubicin in HL60 and its resistant cells and comparison with those of pirarubicin . Biol. Pharm. Bull. , 19 , 100 – 105 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 7).Nagasawa , K. , Natazuka , T. , Chihara , K. , Kitazawa , F. , Tsumura , A. , Takara , K. , Nomiyama , M. , Ohnishi , N. and Yokoyama , T.Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin‐resistant HL60 cells . Cancer Chemother. Pharmacol. , 37 , 297 – 304 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 8).Nagasawa , K. , Ohnishi , N. and Yokoyama , T.Transport mechanisms of idarubicin, an anthracycline derivative, in human leukemia HL60 cells and mononuclear cells, and comparison with those of its analogs . Jpn. J. Cancer Res. , 88 , 750 – 759 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9).Nagasawa , K. , Ohnishi , N. and Yokoyama , T.Possibility of contribution of nucleoside transport system to pirarubicin uptake by HL60 cells but not mononuclear cells . Jpn. J. Cancer Res. , 89 , 673 – 680 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10).Talmadge , J. E. , Key , M. E. and Hart , I. R.Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin . Cancer Res. , 41 , 1271 – 1280 ( 1981. ). [PubMed] [Google Scholar]
- 11).Talmadge , J. E. and Hart , I. R.Morphologic studies on a murine reticulum cell sarcoma (histiocytic sarcoma) of histiocytic origin and its metastasis . Vet. Pathol. , 20 , 342 – 352 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 12).Hart , I. R. , Talmadge , J. E. and Fidler , I. J.Metastatic behavior of a murine reticulum cell sarcoma exhibiting organ‐specific growth . Cancer Res. , 41 , 1281 – 1287 ( 1981. ). [PubMed] [Google Scholar]
- 13).Sugiyama , T. and Sadzuka , Y.Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma . Cancer Lett. , 133 , 19 – 26 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 14).Tsuruo , T. , Iida , H. , Tsukagoshi , S. and Sakurai , Y.4′‐O‐Tetrahydropyranyladriamycin as a potential new antitumor agent . Cancer Res. , 42 , 1462 – 1467 ( 1982. ). [PubMed] [Google Scholar]
- 15).Sadzuka , Y. , Sugiyama , T. , Miyagishima , A. , Nozawa , Y. and Hirota , S.The effects of theanine, as a novel biochemical modulator, on the antitumor activity of adriamycin . Cancer Lett. , 105 , 203 – 209 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 16).Sadzuka , Y. , Sugiyama , T. and Hirota , S.Modulation of cancer chemotherapy by green tea . Clin. Cancer Res. , 4 , 153 – 156 ( 1998. ). [PubMed] [Google Scholar]
- 17).Graham , H. N.Green tea composition, consumption, and polyphenol chemistry . Prev. Med. , 21 , 334 – 350 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 18).Kunimoto , S. , Miura , K. , Takahashi , Y. , Takeuchi , T. and Umezawa , H.Rapid uptake by cultured tumor cells and intracellular behavior of 4′‐O‐tetrahydropypanyladriamy‐cin . J. Antibiot. , 36 , 312 – 317 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 19).Pieters , R. , Huismans , D. R. , Loonen , A. H. , Hahlen , K. , Berg , A.van der Dose‐van den, Wering , E. R. and Veer‐man , A. J. P.Relation of cellular drug resistance to long term clinical outcome in childhood acute lymphoblastic leukemia . Lancet , 338 , 399 ( 1991. ). [DOI] [PubMed] [Google Scholar]